Those with a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, or previous episodes of pancreatitis need thorough medical evaluation before starting treatment
For people with overweight or obesity and pre-existing cardiovascular disease (CVD), taking semaglutide for three years resulted in 20% fewer heart attacks, strokes, and deaths, compared to those taking a placebo, according to the new study
Curiously, it was recently reported that this pro-inflammatory cytokine, IL-6, similarly, but independently from GLP-1, slows gastric emptying (228)
Retatrutide reduces appetite and food intake significantly